Webb14 feb. 2024 · When Plk1-targeting siRNNs were applied to primary blood and bone marrow mononuclear cells from eight pediatric B-ALL patients, cultured ex vivo, Plk1 knockdown was detected in seven of the treated patient samples, independently of genetics or blood/bone marrow origin. Webb14 feb. 2024 · When Plk1-targeting siRNNs were applied to primary blood and bone marrow mononuclear cells from eight pediatric B-ALL patients, cultured ex vivo, Plk1 knockdown …
Cells Free Full-Text MAP4K4/JNK Signaling Pathway Stimulates ...
Webb15 nov. 2024 · Here we identify that Polo-like kinase 1 (Plk1), a key regulator for cell mitosis, plays a critical role for biosynthesis in cancer cells through activating pentose … Webb14 feb. 2024 · In our previous T-ALL study 9, we found that RNAi prodrugs targeting Plk1 could enter primary cells from T-ALL patients and induce knockdown of Plk1 mRNA … patricia dinger allergist
CDK1-PLK1/SGOL2/ANLN pathway mediating abnormal cell division in cell …
Webb10 apr. 2024 · Subsequently, tumor tissue sections were blocked in 10% normal horse serum and 0.3% triton X-100 for 1 h, then incubated with the indicated primary antibody diluted in 2.5% normal horse serum blocking solution: The used primary antibodies: PD-L1 (13684, Cell Signaling Technology), CD8α (98941, Cell Signaling Technology), and … Webb10 apr. 2024 · The transfection of siCDK1 in SK-Hep1 resulted in a disordered cell cycle. Furthermore, CDK1 knockdown suppressed the expression of PLK1, ANLN, and SGOL2. The CDK1-PLK1/SGOL2/ANLN pathway mediating abnormal cell division in the cell cycle might be a critical process in HCC. KEYWORDS: Hepatocellular carcinoma, CDK1, PLK1, … Webb12 juni 2014 · Cell viability of sh PLK1 cells was normalized with that of shControl cells; right, western blot analysis for the indicated proteins in PLK1-knockdown cells by shRNA in LNCaP is shown. sh PLK1, shRNA targeting PLK1; shControl, control shRNA. D, left, relative cell viability of PLK1 -knockdown PC3 cells. patricia dimango new show